Dose Reduction for Early Rheumatoid Arthritis Patients With Low Disease Activity

NCT02466581 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: Sulphasalazine + Hydroxychloroquine OR Prednisolone
BIOLOGICAL: Cimzia
BIOLOGICAL: Orencia
BIOLOGICAL: RoActemra

Sponsor

Karolinska Institutet